These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23200184)

  • 1. Clinical impact of drug-drug interaction between aspirin and prednisolone at a cancer center.
    Koomanan N; Ko Y; Yong WP; Ng R; Wong YP; Lim SW; Salim A; Chan A
    Clin Ther; 2012 Dec; 34(12):2259-67. PubMed ID: 23200184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aspirin cardiovascular/gastrointestinal risk calculator--a tool to aid clinicians in practice.
    Lanas A; Polo-Tomás M; Casado-Arroyo R
    Aliment Pharmacol Ther; 2013 Apr; 37(7):738-48. PubMed ID: 23413984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.
    Hachiken H; Murai A; Wada K; Kuwahara T; Hosomi K; Takada M
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):807-15. PubMed ID: 24040850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
    Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study.
    Tamura A; Murakami K; Kadota J;
    QJM; 2011 Feb; 104(2):133-9. PubMed ID: 20870780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of upper gastrointestinal symptoms in patients receiving low-dose acetylsalicylic acid for cardiovascular risk management: a prospective observational study.
    Bytzer P; Pratt S; Elkin E; Næsdal J; Sörstadius E
    Am J Cardiovasc Drugs; 2013 Feb; 13(1):27-35. PubMed ID: 23315343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal tolerability of aspirin and the choice of over-the-counter analgesia for short-lasting acute pain.
    Steiner TJ; Voelker M
    J Clin Pharm Ther; 2009 Apr; 34(2):177-86. PubMed ID: 19250138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.
    Gesheff MG; Franzese CJ; Bliden KP; Contino CJ; Rafeedheen R; Tantry US; Gurbel PA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):645-53. PubMed ID: 25098174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
    Scheiman JM; Hindley CE
    Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper GI bleeding requires prompt investigation.
    Hopper AD; Sanders DS
    Practitioner; 2011; 255(1742):15-9, 2. PubMed ID: 21932501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K; Hughes JD; Lee YP; Parsons R
    Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
    Fries JF; Bruce B
    J Rheumatol; 2003 Oct; 30(10):2226-33. PubMed ID: 14528521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
    Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
    Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of upper gastrointestinal symptoms on nonadherence to, and discontinuation of, low-dose acetylsalicylic acid in patients with cardiovascular risk.
    Pratt S; Thompson VJ; Elkin EP; Næsdal J; Sörstadius E
    Am J Cardiovasc Drugs; 2010; 10(5):281-8. PubMed ID: 20666569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
    Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR
    Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.